{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-028208","form_type":"8-K","ticker":"CRNX","cik":"0001658247","company_name":"Crinetics Pharmaceuticals, Inc.","filed_at":"2026-07-10T20:01:22+00:00","discovered_at":"2026-07-10T20:03:00.332287+00:00","generated_at":"2026-07-10T20:03:18.452355+00:00","sec_items":["1.01","5.02"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"medium","headline":"Crinetics enters into merger agreement with Vertex Pharmaceuticals","bullets":["Merger agreement signed July 6, 2026; Crinetics to become wholly owned subsidiary of Vertex.","Non-compete agreements with CEO Scott Struthers, CFO Tobin Schilke, CSO Stephen Betz, CCO Isabel Kalofonos.","Cash payments at closing: Schilke $140,000, Betz $30,000, Kalofonos $30,000.","No financial terms (price, premium) disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-028208","json":"https://secwatch.observer/filing/0001140361-26-028208.json","markdown":"https://secwatch.observer/filing/0001140361-26-028208.md","text":"https://secwatch.observer/filing/0001140361-26-028208.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1658247/000114036126028208/0001140361-26-028208-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1658247/000114036126028208/crnx-20260706.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-10T20:03:18.452355+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}